EMAIL THIS PAGE TO A FRIEND

Cancer prevention research (Philadelphia, Pa.)

Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans.


PMID 25804610

Abstract

The transcription factor Nrf2 determines the ability to adapt and survive under conditions of electrophilic, oxidative, and inflammatory stress by regulating the expression of elaborate networks comprising nearly 500 genes encoding proteins with versatile cytoprotective functions. In mice, disruption of Nrf2 increases susceptibility to carcinogens and accelerates disease pathogenesis. Paradoxically, Nrf2 is upregulated in established human tumors, but whether this upregulation drives carcinogenesis is not known. Here we show that the incidence, multiplicity, and burden of solar-simulated UV radiation-mediated cutaneous tumors that form in SKH-1 hairless mice in which Nrf2 is genetically constitutively activated are lower than those that arise in their wild-type counterparts. Pharmacologic Nrf2 activation by topical biweekly applications of small (40 nmol) quantities of the potent bis(cyano enone) inducer TBE-31 has a similar protective effect against solar-simulated UV radiation in animals receiving long-term treatment with the immunosuppressive agent azathioprine. Genetic or pharmacologic Nrf2 activation lowers the expression of the pro-inflammatory factors IL6 and IL1β, and COX2 after acute exposure of mice to UV radiation. In healthy human subjects, topical applications of extracts delivering the Nrf2 activator sulforaphane reduced the degree of solar-simulated UV radiation-induced skin erythema, a quantifiable surrogate endpoint for cutaneous damage and skin cancer risk. Collectively, these data show that Nrf2 is not a driver for tumorigenesis even upon exposure to a very potent and complete carcinogen and strongly suggest that the frequent activation of Nrf2 in established human tumors is a marker of metabolic adaptation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV54576
Anti-GCLC antibody produced in rabbit, affinity isolated antibody
HPA036359
Anti-GCLC antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA036360
Anti-GCLC antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV34727
Anti-KEAP1 (AB1) antibody produced in rabbit, affinity isolated antibody
AV38981
Anti-KEAP1 (AB2) antibody produced in rabbit, affinity isolated antibody
SAB2501696
Anti-KEAP1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
K3144
Anti-Keap1 antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA005558
Anti-KEAP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV34728
Anti-KEAP1 antibody produced in rabbit, IgG fraction of antiserum, lyophilized powder
SAB2501713
Anti-NFE2L2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA002990 Anti-NFE2L2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2701989
Anti-NFE2L2 antibody produced in rabbit
SAB4501984
Anti-NRF2, C-Terminal antibody produced in rabbit, affinity isolated antibody
A4638
Azathioprine, ≥98%
C9H7N7O2S
M5625
Menadione, crystalline
C11H8O2
M9429
Menadione, meets USP testing specifications
C11H8O2
M57405
Menadione, 98%
C11H8O2
WH0002729M1
Monoclonal Anti-GCLC antibody produced in mouse, clone 3H1, purified immunoglobulin, buffered aqueous solution
K2769
Monoclonal Anti-Keap1 antibody produced in mouse, ~1.0 mg/mL, clone Keap1-2, purified immunoglobulin, buffered aqueous solution
WH0004780M1
Monoclonal Anti-NFE2L2 antibody produced in mouse, clone 1F3, purified immunoglobulin, buffered aqueous solution
SAB1404123
Monoclonal Anti-NFE2L2 antibody produced in mouse, clone 2G7, purified immunoglobulin, buffered aqueous solution
SAB1409360
Monoclonal Anti-NFE2L2 antibody produced in mouse, clone 3G7, purified immunoglobulin, buffered aqueous solution
SAB1409361
Monoclonal Anti-NFE2L2 antibody produced in mouse, clone 2D5, purified immunoglobulin, buffered aqueous solution
SAB1409362
Monoclonal Anti-NFE2L2 antibody produced in mouse, clone 4C3, purified immunoglobulin, buffered aqueous solution
SAB1409363
Monoclonal Anti-NFE2L2 antibody produced in mouse, clone 1G10, purified immunoglobulin, buffered aqueous solution